Table of Contents
ISRN Rehabilitation
Volume 2013, Article ID 807546, 10 pages
http://dx.doi.org/10.1155/2013/807546
Research Article

Clinical Characteristics and Course of Patients Entering Cardiac Rehabilitation with Chronic Kidney Disease: Data from the Italian Survey on Cardiac Rehabilitation

1Department of Translational Medical Sciences, Cardiac Rehabilitation Unit, University of Naples “Federico II,” Via S. Pansini 5, 80131 Naples, Italy
2Department of Critical Care Medicine and Surgery, Cardiac Rehabilitation Unit, University of Florence and Azienda Ospedaliero-Universitaria Careggi, Via delle Oblate 4, 50141 Florence, Italy
3Division of Cardiac Rehabilitation, Fondazione Europea di Ricerca Biomedica, Via Uboldo 56, 20063 Cernusco S/N, Italy
4Clinica “Le Terrazze,” Via Foscolo 6/B, 21035 Cunardo, Italy
5Cardiac Rehabilitation Unit, Department of Cardiology, La Colletta Hospital, Via del Giappone, 16011 Arenzano, Italy
6Azienda Ospedaliera S. Anna e S. Sebastiano di Caserta, Via Gennaro Tescione 1, 81100 Caserta, Italy

Received 13 May 2013; Accepted 9 June 2013

Academic Editors: Y. Hu, Y. Laufer, and M. Probst

Copyright © 2013 Francesco Giallauria et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

This survey shows the clinical risk profile, resource utilization, pharmacologic treatment, and course of cardiac rehabilitation (CR) programs in patients with chronic kidney disease (CKD). Data from 165 CR units in Italy were collected online from January 28 to February 10, 2008. The study cohort consisted of 2281 patients: 200 CKD patients and 2081 non-CKD patients. CKD patients were older and showed more comorbidity and complications during CR, a more complex clinical course and interventions with less functional evaluation, and a different pattern of drug therapy at hospital discharge. CKD patients had higher mortality during CR programs due to heart failure, respiratory insufficiency, and cognitive impairment. These findings suggest that patients with CKD should not be denied access to CR, provided careful attention to clinical status, possible complications, optimization of drug therapy, and close followup.